Madrigal Pharmaceuticals, Inc. (MDGL)
NMS – Real Time Price. Currency in USD
532.46
-2.81 (-0.52%)
Market open: Aug 12, 2026, 10:00 AM EDT
534.99
-0.28 (-0.05%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
532.46
-2.81 (-0.52%)
Market open: Aug 12, 2026, 10:00 AM EDT
534.99
-0.28 (-0.05%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Total debt $347.8M significantly exceeds cash reserves ($292.9M), raising financial stability concerns
Total current assets $1.2B exceed Total current liabilities $374.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.7) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-7.1x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $19.1M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.20 | 6.05 | 10 | |
| Quick ratio | 2.94 | 5.63 | 10 | |
| Debt to Equity | 0.66 | 0.30 | 7.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | -7.09 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 180M | 958M | 1.28B |
| Gross Profit | -467K | -527K | 173M | 901M | 1.17B |
| Operating Income | -294M | -380M | -498M | -300M | -323M |
| Net Income | -295M | -374M | -466M | -288M | -325M |
| EBITDA | -293M | -380M | -497M | -299M | -321M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 40.7 | 83.04 | 10 |
| Next quarter | 38.2 | 92.8 | 10 |
| Current year | 59.08 | 51.27 | 10 |
| Next year | 41.29 | 204.62 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 17 | 38.62 | 38.77 | 111.14 | 9.8 |
| Y/Y | 71.17 | -37.02 | -4.73 | 140.54 | 5.5 |
| 3y average | 810.02 | -4.34 | 5.26 | -8.85 | 4.3 |
| 5y average | 885.61 | -10.94 | -2.74 | -13.07 | 3.3 |
| Weighted average score | 5.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 7.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Medium | 7.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 4.0 |
| Weighted average score | 5.4 | |